Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Pharmacopsychiatry
|
January 1, 1986
Approaches to the assessment of schizophrenia in Europe
P Berner, W Kieffer, M Musalek, et al.
Neuropsychobiology
|
January 1, 1989
Effect of lithium on the EEG of healthy males and females. A probability mapping study
K Thau, P Rappelsberger, A Lovrek, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2001
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial
N Hergovich, E Singer, E Agneter, et al.
Pharmacopsychiatry
|
March 1, 1989
Computerized documentation for lithium outpatients (routine and research data)
C Simhandl, K Thau, R Wolf, et al.
Acta Psychiatrica Scandinavica
|
September 1, 1992
The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness
B Müller-Oerlinghausen, B Ahrens, E Grof, et al.
Journal of Affective Disorders
|
February 21, 1995
Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis
B Ahrens, B Müller-Oerlinghausen, M Schou, et al.
Psychiatry Research
|
March 1, 1991
Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI
B Müller-Oerlinghausen, B Ahrens, J Volk, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1994
Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients
B Müller-Oerlinghausen, T Wolf, B Ahrens, et al.
Neuropsychobiology
|
January 1, 1992
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder
W W Fleischhacker, H Hinterhuber, H Bauer, et al.
Acta Psychiatrica Scandinavica
|
November 1, 1996
Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI)
B Müller-Oerlinghausen, T Wolf, B Ahrens, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Pharmacopsychiatry
|
January 1, 1986
Approaches to the assessment of schizophrenia in Europe
P Berner, W Kieffer, M Musalek, et al.
Neuropsychobiology
|
January 1, 1989
Effect of lithium on the EEG of healthy males and females. A probability mapping study
K Thau, P Rappelsberger, A Lovrek, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2001
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men. a randomized, double-blind, placebo-controlled trial
N Hergovich, E Singer, E Agneter, et al.
Pharmacopsychiatry
|
March 1, 1989
Computerized documentation for lithium outpatients (routine and research data)
C Simhandl, K Thau, R Wolf, et al.
Acta Psychiatrica Scandinavica
|
September 1, 1992
The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness
B Müller-Oerlinghausen, B Ahrens, E Grof, et al.
Journal of Affective Disorders
|
February 21, 1995
Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis
B Ahrens, B Müller-Oerlinghausen, M Schou, et al.
Psychiatry Research
|
March 1, 1991
Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI
B Müller-Oerlinghausen, B Ahrens, J Volk, et al.
Acta Psychiatrica Scandinavica
|
October 1, 1994
Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients
B Müller-Oerlinghausen, T Wolf, B Ahrens, et al.
Neuropsychobiology
|
January 1, 1992
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder
W W Fleischhacker, H Hinterhuber, H Bauer, et al.
Acta Psychiatrica Scandinavica
|
November 1, 1996
Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI)
B Müller-Oerlinghausen, T Wolf, B Ahrens, et al.
Page
of 3